Search results
- (-) Remove Press releases filter Press releases
Oxford BioMedica Announces Issue of Key US Patent Relating to RNA Interference Using Lentiviral Vector Technology
- Leading intellectual property position further strengthened --
Oxford BioMedica plc Board Change
-- Appointment of New Non-Executive Director --
Oxford BioMedica Announces Collaboration With Immune Design Corp.
Oxford, UK and Seattle, WA, USA – 27 September 2012: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE: OXB), the le
Oxford BioMedica Announces Positive DSMB Review of Ongoing RetinoStat® and StarGen™ Clinical Studies
-- Treatment of final RetinoStat® patient cohort underway --
Oxford BioMedica Plc Announces Results of Firm Placing and Open Offer
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, I